Sanofi

Average Profitability
5.16%
Insider Buys Quantity
63
Insider Buys Sum
$2.76B
Insider Sells Quantity
7
Insider Sells Sum
$11.95B

Insider Activity of Sanofi

The largest purchase of all time was on 2015-01-26 and amounted to 1294896 shares of Alnylam Pharmaceuticals, Inc. for $123.02M.

The largest sale of all time was on 2020-05-29 and amounted to 22821451 share of Regeneron Pharmaceuticals, Inc. for $11.64B.

Biography of Sanofi

No biography is available at this moment.

2021-09-14PurchaseTelesis Bio, Inc.
TBIO
10 percent owner
71.98M
–
$38.00$2.74B-48.86%
2020-07-28PurchaseInozyme Pharma, Inc.
INZY
10 percent owner
162,500
0.7909%
$16.00$2.6M+19.03%
2020-06-09SaleRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
120,234
0.1077%
$597.48$71.84M-14.96%
2020-05-29SaleRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
22.82M
17.324%
$509.85$11.64B-13.71%
2020-03-09SaleRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
128,914
0.1212%
$489.65$63.12M+17.75%
2019-09-10SaleRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
172,904
0.1566%
$281.15$48.61M+62.68%
2019-07-22PurchaseFulcrum Therapeutics, Inc.
FULC
10 percent owner
187,500
1.3178%
$16.00$3M+2.11%
2019-03-08SaleRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
131,115
0.1232%
$412.17$54.04M-19.49%
2018-09-06SaleRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
104,552
0.0989%
$406.68$42.52M-9.36%
2018-06-08SaleRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
121,601
0.1132%
$309.31$37.61M+21.88%
2017-08-24PurchaseRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
105,820
0.0985%
$482.04$51.01M-24.23%
2017-08-23PurchaseRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
60,595
0.057%
$478.98$29.02M-22.94%
2017-06-02PurchaseRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
136,050
0.1277%
$478.17$65.06M-19.84%
2017-05-31PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
595,002
0.7415%
$71.87$42.76M+75.06%
2016-06-14PurchaseRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
64,731
0.0614%
$363.86$23.55M+4.19%
2016-02-17PurchaseRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
80,000
0.076%
$393.71$31.5M-3.34%
2016-02-16PurchaseRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
81,157
0.0777%
$391.23$31.75M-1.92%
2016-02-01PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
410,060
0.4809%
$69.75$28.6M-14.22%
2016-01-12PurchaseRegeneron Pharmaceuticals, Inc.
REGN
10 percent owner
83,938
0.0788%
$465.04$39.03M-17.81%
2015-11-16PurchaseVoyager Therapeutics, Inc.
VYGR
250,000
4.6915%
$14.00$3.5M-30%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.